These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 11008128)
1. Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors. Mimnaugh EG; Yunmbam MK; Li Q; Bonvini P; Hwang SG; Trepel J; Reed E; Neckers L Biochem Pharmacol; 2000 Nov; 60(9):1343-54. PubMed ID: 11008128 [TBL] [Abstract][Full Text] [Related]
2. Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells. Yunmbam MK; Li QQ; Mimnaugh EG; Kayastha GL; Yu JJ; Jones LN; Neckers L; Reed E Int J Oncol; 2001 Oct; 19(4):741-8. PubMed ID: 11562749 [TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition suppresses cisplatin-dependent ERCC-1 mRNA expression in human ovarian tumor cells. Li QQ; Ding L; Reed E Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):387-96. PubMed ID: 11589365 [TBL] [Abstract][Full Text] [Related]
4. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response. Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160 [TBL] [Abstract][Full Text] [Related]
5. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression. Li QQ; Yunmbam MK; Zhong X; Yu JJ; Mimnaugh EG; Neckers L; Reed E Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL61-72. PubMed ID: 11936875 [TBL] [Abstract][Full Text] [Related]
6. Caspase-dependent deubiquitination of monoubiquitinated nucleosomal histone H2A induced by diverse apoptogenic stimuli. Mimnaugh EG; Kayastha G; McGovern NB; Hwang SG; Marcu MG; Trepel J; Cai SY; Marchesi VT; Neckers L Cell Death Differ; 2001 Dec; 8(12):1182-96. PubMed ID: 11753566 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro. Milligan SA; Nopajaroonsri C Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767 [TBL] [Abstract][Full Text] [Related]
8. Proteasomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells. Ullrich O; Grune T Free Radic Biol Med; 2001 Oct; 31(7):887-93. PubMed ID: 11585707 [TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma induces apoptosis of lens alphaTN4-1 cells and proteasome inhibition has an antiapoptotic effect. Awasthi N; Wagner BJ Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):222-9. PubMed ID: 14691177 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins. Soldatenkov VA; Dritschilo A Cancer Res; 1997 Sep; 57(18):3881-5. PubMed ID: 9307264 [TBL] [Abstract][Full Text] [Related]
12. Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells. Li Q; Yu JJ; Mu C; Yunmbam MK; Slavsky D; Cross CL; Bostick-Bruton F; Reed E Anticancer Res; 2000; 20(2A):645-52. PubMed ID: 10810335 [TBL] [Abstract][Full Text] [Related]
13. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells. Gatti L; Benedetti V; De Cesare M; Corna E; Cincinelli R; Zaffaroni N; Zunino F; Perego P J Inorg Biochem; 2012 Aug; 113():94-101. PubMed ID: 22717676 [TBL] [Abstract][Full Text] [Related]
15. Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo. Guichard S; Arnould S; Hennebelle I; Bugat R; Canal P Anticancer Drugs; 2001 Oct; 12(9):741-51. PubMed ID: 11593056 [TBL] [Abstract][Full Text] [Related]
16. Synthetic chenodeoxycholic acid derivative HS-1200-induced apoptosis of p815 mastocytoma cells is augmented by co-treatment with lactacystin. Seo SY; Jun EJ; Jung SM; Kim KH; Lim YJ; Park BS; Kim JK; Lee S; Suh H; Kim ND; Yoo YH Anticancer Drugs; 2003 Mar; 14(3):219-25. PubMed ID: 12634616 [TBL] [Abstract][Full Text] [Related]
17. Chromatin restoration following nucleotide excision repair involves the incorporation of ubiquitinated H2A at damaged genomic sites. Zhu Q; Wani G; Arab HH; El-Mahdy MA; Ray A; Wani AA DNA Repair (Amst); 2009 Feb; 8(2):262-73. PubMed ID: 19059499 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene. Yu JJ; Lee KB; Mu C; Li Q; Abernathy TV; Bostick-Bruton F; Reed E Int J Oncol; 2000 Mar; 16(3):555-60. PubMed ID: 10675489 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin-induced apoptosis in 43-3B and 27-1 cells defective in nucleotide excision repair. Dunkern TR; Fritz G; Kaina B Mutat Res; 2001 Sep; 486(4):249-58. PubMed ID: 11516928 [TBL] [Abstract][Full Text] [Related]
20. Early mitochondrial hyperpolarization and intracellular alkalinization in lactacystin-induced apoptosis of retinal pigment epithelial cells. Kim JM; Bae HR; Park BS; Lee JM; Ahn HB; Rho JH; Yoo KW; Park WC; Rho SH; Yoon HS; Yoo YH J Pharmacol Exp Ther; 2003 May; 305(2):474-81. PubMed ID: 12606642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]